top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
AtaCor Medical raises $75M to fund pivotal U.S. trial of extravascular ICD system
San Clemente, CA, October 6, 2025 (PRNewswire) -- AtaCor Medical secured $75 million to support its U.S. FDA pivotal study of the...
Solarea Bio appoints Catherine Balsam-Schwaber as CEO ahead of launch of first synbiotic for menopausal bone health
Boston, MA, October 3, 2025 (PRNewswire) -- Solarea Bio announced the appointment of Catherine Balsam-Schwaber as Chief Executive...
Crystalys Therapeutics emerges from stealth with $205M Series A to advance late-stage gout therapy
San Diego, CA, September 30, 2025 (Reuters) -- Crystalys Therapeutics announced its launch from stealth with a $205 million Series A...
Harrow appoints new leadership at ImprimisRx to drive next phase of growth
Nashville, TN, October 6, 2025 (Globe Newswire) -- Harrow (Nasdaq: HROW) announced leadership changes at its subsidiary ImprimisRx,...
Merck completes $10B acquisition of Verona Pharma, adding first-in-class COPD therapy Ohtuvayre
Rahway, NJ, October 7, 2025 (Business Wire) -- Merck finalized its $10 billion acquisition of Verona Pharma, making it a wholly owned...
Microbot Medical closes first tranche of preferred investment options raising $25.2M
Hingham, MA, September 16, 2025 (Globe Newswire) -- Microbot Medical announced the first closing of its exercise of outstanding...
Myricx Bio Appoints Mohit Rawat as CEO and Expands Global Team Ahead of Clinical Entry
London, September 22, 2025 (Globe Newswire) -- Myricx Bio, a private biotech developing a novel class of N-myristoyltransferase...
Roche to Acquire 89bio in $3.5B Deal to Advance Liver and Metabolic Therapies
San Francisco, CA, September 17, 2025 (Globe Newswire) -- Roche announced an agreement to acquire 89bio, a clinical-stage biotech...
Takeda Appoints Rhonda Pacheco to Guide U.S. Business
Cambridge, MA, September 24, 2025 (Business Wire) -- Takeda announced that Rhonda Pacheco, formerly Group Vice President of U.S....
Pfizer to Acquire Metsera in $4.9B, Expanding into Obesity and Cardiometabolic Therapies
New York, September 24, 2025 (Business Wire) -- Pfizer announced a definitive agreement to acquire Metsera, a clinical-stage biotech...
Ronovo Surgical Secures $67M to Scale Robotic Surgery and Global Expansion
Shanghai, September 9, 2025 (LinkedIn/Company Statement) -- Ronovo Surgical closed a $67 million Series D financing round led by JJDC,...
ICON Taps COO Barry Balfe as CEO in Strategic Leadership Shift
Dublin, September 10, 2025 (Business Wire) -- ICON plc announced that CEO Steve Cutler will retire on October 1, 2025, and will be...
AbbVie Acquires Gilgamesh’s $1.2B Psychedelic Antidepressant Program to Tackle Major Depression
North Chicago, IL and New York, August  25, 2025 ( PRNewswire ) -- AbbVie will acquire Gilgamesh’s bretisilocin program for up to $1.2...
Galvanize Secures $100M Series C and Appoints Doug Godshall as CEO to Advance PEF Therapies
Redwood City, CA, September 3, 2025 (PRNewswire) -- Galvanize Therapeutics closed an oversubscribed $100 million Series C round led by...
Novartis Bets $1.4B on Inflammation Pathway With Tourmaline Bio Acquisition
Basel, September 9, 2025 (Novartis) -- Novartis will acquire Tourmaline Bio for $1.4 billion, adding pacibekitug—an anti-IL-6 antibody...
Gilead’s Kite Acquires Interius for $350M to Advance In Vivo CAR T-Cell Therapy Platform
Foster City, CA, August 21, 2025 (Reuters) -- Kite Pharma, a Gilead subsidiary, will acquire Interius BioTherapeutics for $350 million...
Bioretec Names Sarah van Hellenberg Hubar-Fisher as CEO to Drive Global Growth in Absorbable Orthopedic Implants
Tampere, Finland, August 27, 2025 (PRNewswire) -- Bioretec Ltd. has appointed Sarah van Hellenberg Hubar-Fisher as Chief Executive...
AbbVie Acquires Gilgamesh’s $1.2B Psychedelic Depression Therapy, Expanding Psychiatry Portfolio
North Chicago, IL and New York, August 25, 2025 (PRNewswire) -- AbbVie will acquire Gilgamesh Pharmaceuticals’ bretisilocin program for...
Zynex Announces New CEO Steven Dyson and Expanded Leadership Team to Drive Growth and Innovation
Englewood, CO, August 18, 2025 (PRNewswire) -- Zynex has appointed Steven Dyson as CEO and filled several critical executive roles to...
Terumo Acquires OrganOx for $1.5B, Expanding into Organ Transplantation with Advanced Preservation Technology
Oxford, UKÂ and Madison, NJ, August 24, 2025 (Globe Newswire) -- Terumo Corporation will acquire OrganOx Limited for approximately $1.5...
bottom of page